Drug Search Results
More Filters [+]

Chlorcyclizine

Alternative Names: chlorcyclizine
Latest Update: 2023-01-31
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: Histamine Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: New Zealand | Portugal | Spain | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Chlorcyclizine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatitis A|Hepatitis C, Chronic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

14-DK-0084

P2

Completed

Hepatitis A|Hepatitis C, Chronic

2014-03-20

Recent News Events